Aether Industries Limited (NSE: AETHER | BSE: 543534)

By Raveendran R | Updated on:

Source: Aether Industries Limited Annual Report FY 2025-26 (Fiscal Year Ended March 31, 2026) 📊 Stock Screeners

Aether Industries Limited is a technology-driven Indian specialty chemicals manufacturer operating at the intersection of advanced organic chemistry, process intensification, and scalable chemical engineering. Headquartered in Surat, Gujarat, the company manufactures differentiated intermediates and specialty performance chemicals for mission-critical end-use applications.

CORE BUSINESS SEGMENTS:
  • Core Advanced Intermediates: 4MEP, T2E, MMBC, NODG, BFA, OTBN, DVL, 10MISB, IDB, and ISBCC. These chemistries serve key therapeutic segments including anti-hypertensives, anti-platelets, anti-psychotics, anti-histamines, NSAIDs, anti-epileptics, and antiretrovirals for HIV/AIDS.
  • Oilfield & Performance Chemicals: Pour point depressants, drag reducing agents, and specialized additives produced exclusively for Baker Hughes and global energy services majors.
  • Material Science & Electronic Chemicals: High-performance polymer additives, low-dielectric monomers, and semiconductor-grade specialty chemicals targeted at printed circuit boards, microelectronics, and AI data infrastructure.
  • Sustainability & Renewables: Converge® CO₂-based polyols technology (licensed from Saudi Aramco Technologies), binding up to 40% carbon dioxide by weight into polyols for CASE (coatings, adhesives, sealants, elastomers) applications, alongside bio-based continuous reaction products developed with SEQENS.
Metrics for FY 2025-26 Ended Mar 31, 2026
PROFIT & LOSS METRICS (₹ CR)
Revenue
₹1,160.14 Cr (▲ 38.0%)
Prev Year: ₹840.55 Cr
Gross Profit
₹396.55 Cr (▲ 45.4%)
Prev Year: ₹272.73 Cr
Operating Profit
₹288.24 Cr (▲ 54.8%)
Prev Year: ₹186.16 Cr
Net Profit
₹219.46 Cr (▲ 38.5%)
Prev Year: ₹158.42 Cr
Gross Margin
34.18 % (▲ 173 bps)
Prev Year: 32.45 %
Operating Margin
24.85 % (▲ 270 bps)
Prev Year: 22.15 %
PAT Margin
18.92 % (▲ 7 bps)
Prev Year: 18.85 %
Asset Turnover
0.36x (▲ 0.04 pts)
Prev Year: 0.32x
RETURN & CAPITAL EFFICIENCY METRICS
ROE
8.94 % (▲ 182 bps)
Prev Year: 7.12 %
ROCE
11.33 % (▲ 321 bps)
Prev Year: 8.12 %
ROA
6.86 % (▲ 86 bps)
Prev Year: 5.99 %
Cash ROE
5.80 % (▲ 130 bps)
Prev Year: 4.49 %
Cash ROCE
5.60 % (▲ 124 bps)
Prev Year: 4.36 %
BALANCE SHEET METRICS (₹ CR)
Total Assets
₹3,201.43 Cr (▲ 21.1%)
Prev Year: ₹2,644.22 Cr
Current Assets
₹1,171.47 Cr (▲ 2.7%)
Prev Year: ₹1,140.52 Cr
Total Liabilities
₹745.54 Cr (▲ 78.2%)
Prev Year: ₹418.33 Cr
Current Liabilities
₹657.34 Cr (▲ 87.4%)
Prev Year: ₹350.70 Cr
Total Equity
₹2,455.89 Cr (▲ 10.3%)
Prev Year: ₹2,225.89 Cr
Working Capital
₹514.13 Cr (▼ 34.9%)
Prev Year: ₹789.82 Cr
Current Ratio
1.78x (▼ 1.47 pts)
Prev Year: 3.25x
Total Debt
₹441.66 Cr (▲ 142.0%)
Prev Year: ₹182.53 Cr
Debt to Equity
0.18x (▲ 0.10 pts)
Prev Year: 0.08x
Debt to Assets
0.14x (▲ 0.07 pts)
Prev Year: 0.07x
Equity Multiplier
1.30x (▲ 0.12 pts)
Prev Year: 1.19x
CASH FLOW METRICS (₹ CR)
Operating Cash Flow
₹142.38 Cr (▲ 42.4%)
Prev Year: ₹100.02 Cr
CapEx
₹383.87 Cr (▲ 31.3%)
Prev Year: ₹292.44 Cr
Free Cash Flow
-₹241.49 Cr (▼ 25.5%)
Prev Year: -₹192.42 Cr
FCF Margin
-20.82 % (▲ 208 bps)
Prev Year: -22.89 %
CF to Debt
0.32x (▼ 0.23 pts)
Prev Year: 0.55x
ROCE (9Y Avg)
28.72 %
FY18–FY26 (9Y Avg)
ROE (9Y Avg)
17.19 %
FY18–FY26 (9Y Avg)

📋 Quick Facts / Company Snapshot: Aether Industries Limited (NSE: AETHER | BSE: 543534)

Attribute Disclosed Detail
Official Company Name Aether Industries Limited
Corporate Identity Number (CIN) L24100GJ2013PLC073434
International Securities Identification Number (ISIN) INE0BWX01014
Stock Exchange Listing National Stock Exchange of India Limited (Symbol: AETHER) | BSE Limited (Scrip Code: 543534)
Date of Incorporation / Founding Year January 23, 2013
Founders / Key Founding Figures Mr. Ashwin Jayantilal Desai, Ms. Purnima Ashwin Desai, Mr. Rohan Ashwin Desai, Dr. Aman Ashwinbhai Desai
Registered Office & Corporate Headquarters Plot No. 8203, GIDC Sachin, Surat – 394230, Gujarat, India
Telephone & Investor Email +91-261-6603000 / +91-261-6603360 | info@aether.co.in / compliance@aether.co.in
Chairman & Managing Director Mr. Kamalvijay Ramchandra Tulsian (Chairman, Non-Executive) | Mr. Ashwin Jayantilal Desai (Managing Director)
Chief Financial Officer & Company Secretary Mr. Faiz Arif Nagariya (CFO) | Mr. Chitrarth Rajan Parghi (CS & Compliance Officer)
Chief Technology Officer Dr. James (Jim) W. Ringer, Ph.D.
Promoter & Holding Group Desai Family (Ashwin Desai, Purnima Desai, Rohan Desai, Dr. Aman Desai & Family Trusts)
Industry / Sector Classification Specialty Chemicals & Advanced Intermediates (NIC Code: 2011 – Manufacture of Chemicals)
Total Workforce / Employees 1,123 Permanent Employees; 1,107 Employees on rolls; 342 Contract Workers (1,449 Total On-Site Workforce)
Manufacturing Facilities Count 5 Manufacturing Campuses (Sites 1, 2, 3, 3++, 4 in Sachin & Hojiwala; Sites 5 & 5+ in Panoli, Gujarat)
Credit Ratings & Rating Agency ICRA A+ (Long-Term Rating) | ICRA A1 (Short-Term Rating) issued by ICRA Limited
Statutory Auditors M/s. Suresh I. Surana & Associates, Chartered Accountants, Surat
Secretarial & Cost Auditors M/s. Dhirren R. Dave & Company (Secretarial) | M/s. PAAA & Associates (Cost Auditors)
Registrar & Share Transfer Agent (RTA) MUFG Intime India Private Limited (formerly Link Intime India Private Limited), Mumbai

🏢 The Corporate Identity: Aether Industries Overview, Promoters & History

The Big Picture: Business Model & Core Value Proposition

Aether Industries Limited is a technology-driven Indian specialty chemicals manufacturer operating at the intersection of advanced organic chemistry, process intensification, and scalable chemical engineering. Headquartered in Surat, Gujarat, the company manufactures differentiated intermediates and specialty performance chemicals for mission-critical end-use applications. Aether’s operational backbone relies on eight core chemistry platforms mastered entirely in-house, serving global leaders across pharmaceuticals, agrochemicals, material sciences, oilfield performance chemicals, coatings, high-performance photography, and electronic chemicals.

The company executes a tripartite business model that balances recurring cash flows with rapid, technology-linked margin expansion. This integrated revenue framework spans three distinct divisions:

  • Large-Scale Manufacturing (LSM): Proprietary production of advanced intermediates where Aether commands dominant market shares. These molecules act as direct import substitutes for critical chemistries historically imported into India from China.
  • Contract / Exclusive Manufacturing (CEM): Long-term, multi-year strategic manufacturing relationships (such as 10-year exclusive contracts) with global multinational majors under take-or-pay and minimum off-take structures.
  • Contract Research and Manufacturing Services (CRAMS): High-value, R&D-led chemical synthesis, process development, and technology scale-up services that feed the company’s commercial pipeline.

The Founders, Promoters & Their Legacy

Aether Industries was established by technocrat promoters with over 125 cumulative years of scientific, operational, and commercial leadership in the chemical industry. The founding executive leadership comprises:

  • Mr. Ashwin Jayantilal Desai (Founding Promoter & Managing Director): A visionary chemical engineer holding a Bachelor’s degree in Chemical Engineering from ICT (formerly UDCT), Mumbai. With over four decades of industry leadership, he steers overall strategic direction, capital allocation, and governance.
  • Ms. Purnima Ashwin Desai (Co-Founder & Executive Director – Finance & Accounts): Over 30 years of corporate finance, administrative, and statutory governance oversight, guiding the company’s capital structure and CSR initiatives.
  • Mr. Rohan Ashwin Desai (Co-Founder & Executive Director – Commercial): Leads global sales, business development, raw material procurement, and customer partnership strategies across domestic and international markets.
  • Dr. Aman Ashwinbhai Desai (Co-Founder & Executive Director – Research & Operations): Holds a Ph.D. in Organic Chemistry from Michigan State University, USA. He architected Aether’s proprietary 8×8 chemistry matrix, leading R&D, process engineering, pilot plant operations, and technology scale-up.

The Journey: Corporate History & Key Milestones

Incorporated in January 2013, Aether spent its initial four years building an scientific engine—constructing analytical laboratories, installing kilo-labs, and erecting the world’s largest Pilot Plant at Manufacturing Facility 1 in Sachin, Surat. Commercial manufacturing commenced in FY 2017-18, delivering first-year revenues of ₹109.20 Crores. Over the following decade, Aether compounded its top line at a CAGR of 30.3%, expanding into dedicated campuses and executing public market raises.

Fiscal Year Key Strategic & Operational Milestones
FY 2013-14 Incorporation of Aether Industries Limited; acquisition of 10,500 sq. meters land for Manufacturing Facility 1 in GIDC Sachin, Surat.
FY 2016-17 R&D facility and world-scale Pilot Plant operationalised; custom SAP B-1 ERP system deployed; workforce crosses 50 professionals.
FY 2017-18 First commercial production commenced at Manufacturing Facility 2; commercialisation of 4MEP; total revenue crosses ₹100 Crores milestone.
FY 2019-20 Commercial launch of BFA; acquisition of land for Manufacturing Facility 3; revenue scales past ₹300 Crores; workforce expands past 400.
FY 2021-22 Commissioning of Manufacturing Facility 3; commercial production of ISBCC; successful Initial Public Offering (IPO) raising capital for expansion; revenue reaches ₹597.00 Crores.
FY 2022-23 Execution of landmark long-term contracts with Baker Hughes and Saudi Aramco Technologies; appointment of Dr. James Ringer as CTO; successful fundraise via QIP of ₹750.00 Crores.
FY 2024-25 Commissioning of Manufacturing Facility 4 (dedicated to Baker Hughes under subsidiary Aether Speciality Chemicals Ltd); acquisition of 60,000 sq. meters land for Site 5+; operationalisation of 15 MW Auto-Tracker Solar Power Plant.
FY 2025-26 Consolidated revenue crosses historical ₹1,160.14 Crores mark; commercialisation of Site 3++ for Milliken & Co.; completion of solvent trials for first two production blocks at Site 5 (Panoli).

The Corporate Umbrella & Group Structure

Aether Industries Limited functions as the flagship operating parent company. It holds a 100% equity stake in its sole material subsidiary, Aether Speciality Chemicals Limited (ASCL), incorporated on September 2, 2022. ASCL operates Manufacturing Facility 4 in Sachin GIDC, Surat, housing dedicated contract manufacturing production blocks for oilfield chemistry majors including Baker Hughes. During FY 2025-26, ASCL generated total revenue of ₹219.97 Crores and a Profit After Tax of ₹49.64 Crores, representing 18.96% of consolidated sales.

⚙️ The Business Engine: Aether Industries Segments, Brands, Products & Operations

The Core Divisions & Segment Revenue Breakdown

In accordance with Ind AS 108, Aether operates in a single primary business segment: the manufacture of specialty chemicals and advanced intermediates. However, management internally monitors performance across three distinct business models. During FY 2025-26, Contract/Exclusive Manufacturing (CEM) surpassed Large-Scale Manufacturing (LSM) to become the single largest revenue driver for the first time in corporate history.

Business Model / Segment FY 2025-26 Revenue (₹ Crores) % Share of Revenue (FY26) FY 2024-25 Revenue (₹ Crores) % Share of Revenue (FY25) Latest YoY (%)
Contract / Exclusive Manufacturing (CEM) 523.44 46.27% 263.01 31.36% +99.02%
Large-Scale Manufacturing (LSM) 489.07 43.23% 462.35 55.13% +5.78%
Contract Research & Manufacturing Services (CRAMS) 104.56 9.24% 102.75 12.25% +1.76%
Other Operating Revenue (Wastage/Scrap Sales) 14.26 1.26% 10.57 1.26% +34.91%
Total Segment Revenue 1,131.34 100.00% 838.69 100.00% +34.89%

The Product & Service Catalog (with Operational KPIs, Order Book & Customer Concentration)

Aether’s commercial portfolio comprises 31 proprietary advanced intermediates and specialty performance chemicals. Each product was developed entirely in-house and launched either as a first-in-India import substitute or a first-in-the-world chemistry innovation. Key portfolio components include:

  • Core Advanced Intermediates: 4MEP, T2E, MMBC, NODG, BFA, OTBN, DVL, 10MISB, IDB, and ISBCC. These chemistries serve key therapeutic segments including anti-hypertensives, anti-platelets, anti-psychotics, anti-histamines, NSAIDs, anti-epileptics, and antiretrovirals for HIV/AIDS.
  • Oilfield & Performance Chemicals: Pour point depressants, drag reducing agents, and specialized additives produced exclusively for Baker Hughes and global energy services majors.
  • Material Science & Electronic Chemicals: High-performance polymer additives, low-dielectric monomers, and semiconductor-grade specialty chemicals targeted at printed circuit boards, microelectronics, and AI data infrastructure.
  • Sustainability & Renewables: Converge® CO₂-based polyols technology (licensed from Saudi Aramco Technologies), binding up to 40% carbon dioxide by weight into polyols for CASE (coatings, adhesives, sealants, elastomers) applications, alongside bio-based continuous reaction products developed with SEQENS.

Operational KPIs, raw material sourcing, and customer concentration metrics disclose a highly technical, defensively insulated operating profile:

  • Customer Concentration (Ind AS 108): Aether serves over 300 customers globally. In FY 2025-26, exactly 1 external customer accounted for ≥10% of total consolidated revenue, contributing ₹219.97 Crores (18.96% of sales), reflecting the scaling Baker Hughes partnership. The top 5 products (BFA, 4MEP, T2E, 10MISB, DVL) accounted for 31.01% of revenue (down from 43.69% in FY25).
  • Capacity Utilisation & Pricing Realisation: Manufacturing plants operated at an aggregate capacity utilisation of ~65% in FY26. Average selling price across the LSM portfolio stood at ₹937 per kg in FY26 (compared to ₹1,306.89 per kg in FY25), driven by volume scale-ups in lower-price-per-kg oilfield performance chemicals.
  • Raw Material Sourcing Split: Raw material consumption totaled ₹682.24 Crores (51.79% of revenue). Imported raw materials accounted for 9.97% of total procurement, while 90.03% was sourced indigenously from domestic chemical suppliers.

The Names You Know: Key Brands & Flagship Portfolio

Brand / Product Family Name Category / Business Segment Target Market & Key Positioning
Converge® CO₂ Polyols Sustainability & Material Science CO₂-based polyol technology licensed from Saudi Aramco Technologies; traps up to 40% carbon dioxide by weight for eco-friendly adhesives, sealants, and elastomeric coatings.
Baker Hughes Oilfield Additives Contract Manufacturing (CEM) Exclusive global supply of specialized pour point depressants and flow-assurance chemicals for crude oil extraction and refining networks.
Milliken Strategic Intermediates Contract / Exclusive Manufacturing 10-year sole contract manufacturing partnership supplying proprietary material science additives to Milliken & Company (USA) out of Site 3++.
Import Substitution Intermediates (4MEP, OTBN, BFA) Large-Scale Manufacturing (LSM) First-in-India proprietary pharmaceutical intermediates replacing Chinese imports for cardiovascular, anti-hypertensive, and anti-convulsant APIs.
Semiconductor Specialty Monomers Electronic Chemicals (Site 5) Ultra-high purity low-dielectric monomers designed for advanced microelectronics, circuit boards, and semiconductor fabrication in Japan, Korea, and Taiwan.

Mapping the Domestic & Global Reach (India vs. Exports)

Aether maintains a dual-market footprint, shipping products to 20 countries while serving a domestic client base of over 250 Indian chemical and pharmaceutical companies. In FY 2025-26, domestic sales expanded rapidly due to the ramp-up of local contract manufacturing deliveries for international majors operating through Indian subsidiaries.

Geographic Market FY 2025-26 Revenue (₹ Crores) % Share of Total Sales (FY26) FY 2024-25 Revenue (₹ Crores) % Share of Total Sales (FY25) Latest YoY (%)
India (Domestic Market) 869.76 74.97% 508.80 60.53% +70.94%
United States of America 85.97 7.41% 57.24 6.81% +50.19%
Germany 59.40 5.12% 41.86 4.98% +41.90%
Netherlands 22.74 1.96% 18.49 2.20% +22.99%
Africa (Rest of World Region) 18.10 1.56% 12.19 1.45% +48.48%
Japan 17.17 1.48% 14.29 1.70% +20.15%
China 16.36 1.41% 14.63 1.74% +11.83%
Czech Republic 15.66 1.35% 12.61 1.50% +24.19%
United Kingdom 13.11 1.13% 10.93 1.30% +19.95%
Italy 8.12 0.70% 6.05 0.72% +34.21%
Total Consolidated Sales 1,160.14 100.00% 840.55 100.00% +38.02%

The Brick & Mortar Footprint: Manufacturing Plants, R&D & Offices

Aether operates five manufacturing campuses covering over 2,24,250 square meters across industrial corridors in Surat and Panoli, Gujarat. All operational plants are automated via Siemens PCS7 and Yokogawa Centum VP Distributed Control Systems (DCS):

  • Site 1 (Sachin GIDC, Surat – 5,250 sq. mtr): Houses the primary R&D centre with 55 fully occupied fume hoods, analytical testing labs, NMR spectroscopy systems, and world-scale Pilot Plant containing 100+ reactors.
  • Site 1+ (Sachin GIDC, Surat – 5,250 sq. mtr): Greenfield R&D expansion under construction (capital outlay ~₹100.00 Crores) adding 120 fume hoods and 15 analytical/engineering laboratories; commissioning scheduled by Q2 FY28.
  • Site 2 (Sachin GIDC, Surat – 10,500 sq. mtr): Large-Scale Manufacturing (LSM) and CEM hub; housing 13,140 MT captive Solvent Recovery Plant (SRP) and zero-liquid discharge effluent treatment assets.
  • Site 3 (Sachin GIDC, Surat – 5,250 sq. mtr): Large-Scale Manufacturing facility operating at 70% capacity utilisation.
  • Site 3++ (Hojiwala Industrial Estate, Surat – 5,250 sq. mtr): Dedicated Contract Manufacturing facility commissioned on February 22, 2026, exclusively producing strategic additives for Milliken & Company under a 10-year contract.
  • Site 4 (Sachin GIDC, Surat – 18,500 sq. mtr): Operated by subsidiary Aether Speciality Chemicals Ltd; houses 4 dedicated production blocks for Baker Hughes oilfield performance chemicals; revenue quadrupled to ₹219.97 Crores in FY26.
  • Site 5 (GIDC Panoli, Bharuch – 1,25,000 sq. mtr): Flagship greenfield campus planned for 16 production blocks. Utilities and Phase 1 solvent/water trials completed; first two production blocks (including dedicated semiconductor chemicals capacity of 400 MTPA) commercialise in Q1 FY27. Total planned capex: ₹2,000 to ₹2,100 Crores.
  • Site 5+ (GIDC Panoli, Bharuch – 60,000 sq. mtr): Acquired in January 2025 for ₹44.69 Crores adjacent to Site 5 to support long-term manufacturing expansion through FY31.
  • Renewable Energy Generation Assets: 16 MW static solar power plant in Sarod, Bharuch + 15 MW auto-tracker solar power plant in Vagra, Bharuch (31 MW total captive solar capacity meeting >75% of power needs for Sites 1, 2, and 3).

📊 The Financial Health: Aether Industries Financial Statements & Numbers Simplified

Multi-Year Financial Highlights (₹ in Crores)

Aether has maintained a compounding growth trajectory over the past nine fiscal years. The multi-year performance summary demonstrates the step-up in revenue, operating earnings, and net profitability following capacity additions across Sites 2, 3, 4, and 3++.

Financial Metric FY 2025-26 FY 2024-25 FY 2023-24 FY 2022-23 FY 2021-22 FY 2020-21 FY 2019-20 FY 2018-19 FY 2017-18 Latest YoY (%)
Revenue from Operations 1,160.14 840.55 598.17 651.07 597.00 453.80 303.80 203.30 109.20 +38.02%
Total Income 1,181.07 880.31 637.38 667.64 597.00 453.80 303.80 203.30 109.20 +34.17%
EBITDA (Operating Profit) 354.66 231.17 118.49 186.25 168.10 112.10 73.80 49.60 23.10 +53.42%
EBITDA Margin (%) 30.57% 27.50% 19.81% 28.61% 28.16% 24.70% 24.30% 24.40% 21.15% –
Profit After Tax (PAT) 219.46 158.42 82.49 130.42 108.90 71.10 39.90 23.30 12.10 +38.53%
PAT Margin (%) 18.58% 18.00% 12.94% 19.53% 18.24% 15.67% 13.13% 11.46% 11.08% –
R&D Expenditure 86.21 68.10 98.70 50.10 39.30 19.30 12.10 5.30 2.80 +26.59%
Total Equity / Net Worth 2,455.89 2,225.89 2,060.00 1,244.00 342.00 231.00 158.00 112.00 78.00 +10.33%

Earnings, Expenses, & Take-Home Profits (Consolidated Profit & Loss)

Consolidated revenue from operations surged 38.02% to ₹1,160.14 Crores in FY 2025-26, driven by a 99% jump in CEM revenues and firm pricing realisations across the LSM product portfolio. EBITDA expanded 53.42% to ₹354.66 Crores, with operating margins expanding by 307 basis points to 30.57% due to operational leverage and a higher share of contract manufacturing.

Consolidated Statement of Profit & Loss (Ind AS) FY 2025-26 (₹ Crores) FY 2024-25 (₹ Crores) Latest YoY (%)
Revenue from Operations 1,160.14 840.55 +38.02%
Other Income 20.93 39.76 -47.36%
TOTAL INCOME 1,181.07 880.31 +34.17%
Cost of Materials Consumed 682.24 507.20 +34.51%
Changes in Inventories of Finished Goods & WIP -₹81.35 -₹60.62 +34.20%
Employee Benefits Expense 62.73 46.21 +35.75%
Finance Costs 18.09 12.93 +39.91%
Depreciation and Amortisation Expense 66.42 45.01 +47.57%
Other Expenses 132.88 104.71 +26.90%
TOTAL EXPENSES 881.01 655.45 +34.41%
Profit Before Exceptional Items & Tax 300.06 224.86 +33.44%
Exceptional Items (Warehouse Fire Premium & Loss Adjustment) 8.98 11.87 -24.35%
Profit Before Tax (PBT) 291.09 212.98 +36.67%
Tax Expense: Current Tax 50.84 38.02 +33.72%
Tax Expense: Deferred Tax 20.79 16.55 +25.62%
PROFIT FOR THE YEAR (PAT) 219.46 158.42 +38.53%
Other Comprehensive Income / (Loss) (Net of Tax) 1.04 -₹0.37 N/M
TOTAL COMPREHENSIVE INCOME FOR THE YEAR 220.51 158.05 +39.52%
Basic Earnings Per Share (₹) 16.55 11.95 +38.49%
Diluted Earnings Per Share (₹) 16.54 11.95 +38.41%

Assets, Borrowings, & Net Worth (Consolidated Balance Sheet)

Total assets expanded by 21.07% to reach ₹3,201.43 Crores as of March 31, 2026, supported by property, plant, and equipment additions at Site 3++ and ongoing capital work-in-progress at Site 5 (Panoli). Net worth (Total Equity) reached ₹2,455.89 Crores, while total debt rose to ₹441.66 Crores in working capital facilities to fund plant inventories and trade receivables.

Consolidated Balance Sheet (Ind AS Schedule III) As at March 31, 2026 (₹ Crores) As at March 31, 2025 (₹ Crores) Latest YoY (%)
ASSETS: Non-Current Assets
Property, Plant and Equipment 1,236.20 943.90 +30.97%
Capital Work-in-Progress (CWIP) 506.11 355.37 +42.42%
Right-of-Use Assets 258.71 172.58 +49.91%
Intangible Assets 1.15 0.77 +49.35%
Intangible Assets Under Development 9.58 7.96 +20.35%
Non-Current Financial Assets: Investments 0.21 0.21 0.00%
Non-Current Financial Assets: Loans 0.85 0.84 +1.19%
Other Non-Current Financial Assets 1.79 2.59 -30.89%
Other Non-Current Assets (Capital Advances & Prepaid Expenses) 15.37 19.48 -21.10%
Total Non-Current Assets 2,029.95 1,503.70 +35.00%
Current Assets
Inventories 537.47 396.87 +35.43%
Trade Receivables 390.05 288.62 +35.14%
Cash and Cash Equivalents 5.66 17.37 -67.42%
Bank Balances Other Than Cash & Cash Equivalents 0.00 221.16 -100.00%
Current Financial Assets: Loans 1.16 0.85 +36.47%
Other Current Financial Assets (Deposits & Claims) 19.99 31.91 -37.36%
Current Tax Assets (Net) 32.62 29.24 +11.56%
Other Current Assets (GST Balances & Advances) 184.53 154.52 +19.42%
Total Current Assets 1,171.47 1,140.52 +2.71%
TOTAL ASSETS 3,201.43 2,644.22 +21.07%
EQUITY AND LIABILITIES: Equity
Equity Share Capital 132.68 132.59 +0.07%
Other Equity (Reserves & Surplus) 2,323.21 2,093.30 +10.98%
TOTAL EQUITY (NET WORTH) 2,455.89 2,225.89 +10.33%
Non-Current Liabilities
Non-Current Financial Liabilities: Borrowings 0.00 0.00 N/M
Non-Current Financial Liabilities: Lease Liabilities 14.24 14.81 -3.85%
Deferred Tax Liabilities (Net) 73.96 52.82 +40.02%
Total Non-Current Liabilities 88.20 67.63 +30.42%
Current Liabilities
Current Financial Liabilities: Borrowings 441.66 182.53 +141.97%
Current Financial Liabilities: Lease Liabilities 2.03 2.53 -19.76%
Trade Payables: Total Outstanding Dues of MSME 12.37 22.11 -44.05%
Trade Payables: Total Outstanding Dues of Non-MSME 184.57 105.45 +75.03%
Other Current Financial Liabilities (Employee Payables) 8.04 5.27 +52.56%
Other Current Liabilities (Statutory Dues & Advances) 1.52 26.56 -94.28%
Current Provisions 7.14 6.25 +14.24%
Total Current Liabilities 657.34 350.70 +87.44%
Total Liabilities (Excluding Equity) 745.54 418.33 +78.22%
TOTAL EQUITY AND LIABILITIES 3,201.43 2,644.22 +21.07%

Working Capital Cycle & Schedule III Statutory Ratio Explanations

Working capital efficiency improved significantly during FY 2025-26 as working capital days decreased from 191 days to 179 days, with management targeting 160 days by FY 2026-27. Management provided mandatory Schedule III variance explanations for key financial ratios:

Statutory Ratio FY 2025-26 FY 2024-25 YoY Variance (%) Management Schedule III Variance Explanation
Current Ratio (x) 1.78x 3.25x -45.20% Variance driven by increase in short-term working capital borrowings to fund raw material stock for new sites.
Debt-Equity Ratio (x) 0.18x 0.08x +119.31% Increase due to drawdown of short-term bank credit facilities to support Site 3++ and Site 5 commissioning.
Debt Service Coverage Ratio (DSCR) (x) 16.53x 15.66x +5.62% Operating earnings growth fully covered the increase in interest expenses.
Return on Equity (ROE) (%) 8.94% 7.12% +25.56% Driven by 38.53% expansion in net profit after tax on higher EBITDA margins.
Inventory Turnover Ratio (x) 2.42x 2.27x +6.93% Higher production turns across Large-Scale Manufacturing lines.
Trade Receivables Turnover Ratio (x) 3.34x 3.22x +3.70% Steady collections from long-term CEM corporate clients.
Trade Payables Turnover Ratio (x) 3.70x 3.86x -4.18% Aligns with short-term supplier payment schedules.
Net Capital Turnover Ratio (x) 1.78x 0.93x +90.89% Variance driven by reduced net working capital relative to total revenue expansion.
Net Profit Margin (%) 219.46 18.85% +0.37% Maintained steady net margin profile despite fourth-quarter warehouse fire losses.
Return on Capital Employed (ROCE) (%) 9.97% 8.58% +16.18% Reflects operating leverage as capital assets at Site 4 and Site 3++ scale up.

Cash Flow: Tracking the Money Movement

Aether generated ₹142.38 Crores in net cash from operating activities during FY 2025-26, representing a 42.35% increase over FY25. This cash generation fully funded the company’s maintenance CapEx, while major greenfield expansion at Site 5 was funded through internal accruals and short-term debt facilities.

Consolidated Cash Flow Statement Summary FY 2025-26 (₹ Crores) FY 2024-25 (₹ Crores) Latest YoY (%)
Net Cash Generated from Operating Activities (A) 142.38 100.02 +42.35%
Purchase of Property, Plant & Equipment and Intangibles (CapEx) 383.87 292.44 +31.26%
Purchase of Leasehold Land (Site 5 Expansion) -₹91.31 -₹11.97 +662.82%
Additions to Capital Work-in-Progress (CWIP) -₹148.13 -₹147.90 +0.16%
Interest Received & Fixed Deposit Movement 3.93 33.84 -88.39%
Net Cash Used in Investing Activities (B) -₹619.38 -₹418.47 +48.01%
Net Proceeds / (Repayments) from Working Capital Facilities 258.91 14.11 +1734.94%
Proceeds from Issue of Shares under ESOP Scheme 4.11 1.28 +221.09%
Interest Paid on Borrowings -₹16.60 -₹11.52 +44.10%
Payment Towards Lease Liabilities -₹2.55 -₹2.53 +0.79%
Net Cash Generated from Financing Activities (C) 243.86 1.25 +19408.80%
Net Increase / (Decrease) in Cash and Cash Equivalents (A+B+C) -₹233.14 -₹317.20 -26.50%
Cash and Cash Equivalents at Beginning of Year 238.53 555.65 -57.07%
Cash and Cash Equivalents at End of Year 5.66 238.53 -97.63%

Funding the Future: CapEx, CWIP, R&D Intensity & Net Foreign Exchange

Aether maintains one of the highest R&D spending intensities in the Indian chemical sector. Total R&D expenditure reached ₹86.21 Crores in FY 2025-26, representing 7.30% of total revenue. Out of this total, ₹51.39 Crores was charged to the Statement of Profit and Loss as core R&D operating expenses, while the remainder was capitalised into laboratory analytical equipment and fume-hood infrastructure.

Pursuant to Section 134(3)(m) of the Companies Act, 2013, the foreign exchange transactions reflect Aether’s active export presence and international raw material sourcing:

  • Total Foreign Exchange Inflow (Earnings): ₹239.73 Crores (FY25: ₹330.99 Crores) generated from direct chemical exports.
  • Total Foreign Exchange Outflow (Usage): ₹57.44 Crores (FY25: ₹48.10 Crores) spent on imported raw materials, international capital equipment, and foreign travel.
  • Net Foreign Exchange Balance: Net positive inflow of ₹182.29 Crores.

👥 Power & Control: Aether Industries Governance, Leadership & Shareholding Pattern

The Brain Trust: Board of Directors & Key Managerial Personnel (KMP)

The Board of Directors comprises 12 members: 4 Executive Directors (all Promoters), 2 Non-Executive Non-Independent Directors, and 6 Independent Directors (including 1 Woman Independent Director). The Board is chaired by Mr. Kamalvijay Ramchandra Tulsian, a Non-Executive Director.

Name of Director / KMP Designation / Role DIN Category
Mr. Ashwin Jayantilal Desai Managing Director 00038386 Executive Promoter
Ms. Purnima Ashwin Desai Whole-Time Director (Finance & Accounts) 00038399 Executive Promoter
Mr. Rohan Ashwin Desai Whole-Time Director (Commercial) 00038379 Executive Promoter
Dr. Aman Ashwinbhai Desai Whole-Time Director (Research & Operations) 00043633 Executive Promoter
Mr. Kamalvijay Ramchandra Tulsian Chairman 00190840 Non-Executive Non-Independent
Ms. Ishita Surendra Manjrekar Director 06731016 Non-Executive Non-Independent
Mr. Jeevan Lal Nagori Director 00017939 Non-Executive Independent
Mr. Arun Brijmohan Kanodiya Director 03449000 Non-Executive Independent
Ms. Leja Satish Hattiangadi Director 00198720 Non-Executive Independent
Mr. Jitendra Popatlal Vakharia Director 00191088 Non-Executive Independent
Dr. Amol Arvindrao Kulkarni Director 09311097 Non-Executive Independent
Mr. Rajkumar Mangilal Borana Director 01091166 Non-Executive Independent
Dr. James (Jim) W. Ringer Chief Technology Officer (CTO) – Key Managerial Personnel
Mr. Faiz Arif Nagariya Chief Financial Officer (CFO) – Key Managerial Personnel
Mr. Chitrarth Rajan Parghi Company Secretary & Compliance Officer – Key Managerial Personnel

Who Owns the Stock? Shareholding Pattern

The Promoter and Promoter Group holds 74.95% of the total issued equity share capital as of March 31, 2026. The remaining 25.05% is held by institutional investors, mutual funds, foreign portfolio investors (FPIs), and public retail shareholders.

Shareholder Category Number of Equity Shares Held % of Total Issued Share Capital
Promoter & Promoter Group 9,94,37,293 74.95%
Institutional Investors (MFs, FPIs, Banks, AIFs) & Public 3,32,42,531 25.05%
Total Issued Equity Share Capital 13,26,79,824 100.00%

A granular breakdown of individual holdings within the Promoter & Promoter Group discloses:

  • Ms. Purnima Ashwin Desai: 2,30,78,230 shares (17.39%)
  • RAD Family Trust (Rohan Desai Trust): 2,00,17,162 shares (15.09%)
  • AAD Business Trust (Aman Desai Trust): 2,00,17,162 shares (15.09%)
  • AJD Family Trust (Ashwin Desai Trust): 1,35,60,206 shares (10.22%)
  • PAD Family Trust (Purnima Desai Trust): 1,35,60,206 shares (10.22%)
  • Mr. Ashwin Jayantilal Desai: 67,20,417 shares (5.07%)
  • Mr. Rohan Ashwin Desai: 22,21,681 shares (1.67%)
  • Dr. Aman Ashwinbhai Desai: 1,10,000 shares (0.08%)
  • Other Family Members & Entities: 1,52,237 shares (0.12%)

🗺️ The Corporate Family Tree: Group Structure, Ratings & Contingent Liabilities

Subsidiaries, Associates, & Joint Ventures (Form AOC-1)

Pursuant to Section 129(3) of the Companies Act, 2013, the financial performance of Aether’s sole wholly owned material subsidiary is summarized below:

Entity Name Relationship Country % Shareholding FY26 Turnover (₹ Crores) FY26 PAT (₹ Crores)
Aether Speciality Chemicals Limited (ASCL) Wholly Owned Material Subsidiary India 100.00% 219.97 49.64

Strategic Investments, Credit Ratings, Banking Consortium & Contingent Liabilities

Aether maintains non-current investments totaling ₹0.21 Crores in equity shares of environmental infrastructure utilities, including Globe Enviro Care Limited (1,16,851 equity shares) and Sachin Industrial Co-Op Society Limited. Credit ratings issued by ICRA Limited stand at ICRA A+ for long-term credit facilities and ICRA A1 for short-term credit facilities across total rated bank facilities of ₹296.00 Crores.

Contingent liabilities and off-balance-sheet commitments as of March 31, 2026 comprise:

  • Bank Guarantees: ₹14.44 Crores issued to statutory and commercial bodies, including Torrent Power / DGVCL (₹11.68 Cr), Gujarat Gas Limited (₹2.09 Cr), and Customs Authorities (₹0.64 Cr).
  • Taxation Disputes & Demands: Outstanding litigations under appeal total ₹4.40 Crores, comprising Income Tax demand for AY 2020-21 (₹0.13 Cr), GST demands for FY 2021-22 (₹4.26 Cr), and minor TDS demands. Additionally, a CGST Show Cause Notice alleging ineligible IPO input tax credit of ₹4.26 Crores is being contested before appellate authorities.
  • Capital Commitments: Estimated value of contracts remaining to be executed on capital accounts (net of capital advances) stands at ₹334.78 Crores (FY25: ₹263.57 Cr), primarily directed toward Site 5 (Panoli) construction.

🎯 The Strategic Outlook: Competitive Moats, Risks, Growth Plans & FAQs

Competitive Advantages & Economic Moats

Aether has built structural economic moats that protect its business model from regional commodity price swings:

  • In-House 8×8 Chemistry Matrix: Mastery over eight distinct chemistry platforms—including Grignard reagents, organolithium reactions, continuous ethylene oxide/isobutylene chemistry, high-pressure hydrogenation, and cross-coupling—allows Aether to execute multi-step synthesis routes that competitors cannot easily replicate.
  • World-Scale Pilot Plant Infrastructure: Operating over 100 automated pilot reactors, Aether accelerates lab-to-plant scale-up cycles to 12–24 months, acting as a magnet for global innovator clients seeking fast-track commercialisation.
  • First-in-India Import Substitution: Portfolio products such as 4MEP, OTBN, BFA, and DVL directly displace Chinese imports in India, securing sticky domestic market share while enabling exports back into China and Europe.
  • Long-Tenor Contractual Insulation: Over 55% of revenues originate from CEM and CRAMS arrangements operating under 10-year exclusive contracts or multi-year take-or-pay terms with global majors like Baker Hughes and Milliken.

What Could Go Wrong? Key Challenges & Business Risks

  • Raw Material Volatility & Geopolitical Supply Disruptions: Key Feedstocks (phenol, ethylene oxide, chlorobenzonitrile) are crude oil derivatives. Escalations in Middle East conflicts directly inflate input costs and ocean freight rates.
  • Short-Term Debt Substitution Risk: Working capital borrowings rose to ₹441.66 Crores to fund inventory build-ups for Site 3++ and Site 5. Management is working to restructure these short-term bank facilities into long-term funding lines.
  • Operational & Hazardous Process Safety Risks: Handling high-pressure hydrogenations and reactive chemistries entails operational hazards. Following the November 2023 Facility 2 fire (reinstatement claim of ₹29.97 Cr with ₹21.00 Cr recovered) and a March 2026 external warehouse fire (₹7.00 Cr inventory loss), process safety controls remain under continuous audit.

The Next Chapter: Growth, Order Pipeline & CapEx Initiatives

Aether has defined a clear execution roadmap for FY 2026-27 and beyond:

  • Commissioning Site 5 (Panoli Mega Campus): The first two production blocks of Phase 1 will commence commercial operations in Q1 FY27, adding dedicated semiconductor-grade specialty chemicals capacity (~400 MTPA). Two additional blocks will be commercialised every six months through FY31 across all 16 planned blocks.
  • Commercial Ramping of Site 3++: Full-year revenue recognition from the dedicated Milliken & Company exclusive contract manufacturing plant.
  • New Product Launches in LSM: Launch of three direct import-substitution molecules (two pharmaceutical and one agrochemical intermediate) priced at USD 30–50 per kg, strengthening domestic self-reliance.
  • Strategic Revenue Target: Shifting the business mix to achieve 70% revenue contribution from higher-margin CRAMS and CEM contracts by FY 2029-30, guiding to EBITDA margins of 29–30% and PAT margins of 19–20% in FY27.

The Verdict: Strategic Outlook & Conclusion

Aether Industries has transitioned from an early-stage specialty manufacturer into an institutional-grade chemical synthesis platform. With consolidated revenue crossing ₹1,160.14 Crores, EBITDA reaching ₹354.66 Crores, and a expanding manufacturing presence across Sites 4, 3++, and 5, the company is well positioned to capture market share driven by the global “China Plus One” supply chain realignment.

Frequently Asked Questions (FAQs) About Aether Industries

Q1: What does Aether Industries manufacture, and what are its core business models?

Aether Industries manufactures advanced intermediates and specialty performance chemicals for pharmaceuticals, agrochemicals, material sciences, oilfield performance chemicals, coatings, and electronics. It operates three business models: Large-Scale Manufacturing (LSM) of proprietary import substitutes, Contract / Exclusive Manufacturing (CEM) under multi-year contracts, and Contract Research and Manufacturing Services (CRAMS).

Q2: What were Aether Industries’ revenue and net profit in FY 2025-26?

In FY 2025-26, Aether Industries reported consolidated revenue from operations of ₹1,160.14 Crores (up 38.02% YoY from ₹840.55 Crores) and a Profit After Tax (PAT) of ₹219.46 Crores (up 38.02% YoY from ₹158.42 Crores).

Q3: Who are the key promoters and technology leaders of Aether Industries?

The company was founded by the Desai family. Mr. Ashwin Jayantilal Desai is the Founding Promoter & Managing Director, Ms. Purnima Desai is Executive Director (Finance & Accounts), Mr. Rohan Desai is Executive Director (Commercial), and Dr. Aman Desai is Executive Director (Research & Operations). Global R&D is headed by Chief Technology Officer Dr. James (Jim) W. Ringer.

Q4: Where are Aether’s manufacturing plants located, and what is its export share?

Aether operates five manufacturing campuses covering over 2,24,250 sq. meters across Sachin GIDC (Surat), Hojiwala Industrial Estate (Surat), and Panoli GIDC (Bharuch) in Gujarat, India. In FY 2025-26, direct exports and deemed exports accounted for 25.03% of total sales (₹239.73 Crores), reaching 20 countries including the USA, Germany, the Netherlands, Japan, and China.

Q5: What is Aether Industries’ balance sheet strength, credit rating, and net worth?

As of March 31, 2026, Aether’s Net Worth (Total Equity) stood at ₹2,455.89 Crores against total debt of ₹441.66 Crores (Debt-to-Equity ratio of 0.18x). The company holds a long-term credit rating of ICRA A+ and a short-term credit rating of ICRA A1 from ICRA Limited.

Note: Financial ratios, margins, YoY growth percentages, and % revenue shares are calculated by IndianCompanies.in based on disclosed Ind AS financial statements.

Official Site: https://www.aether.co.in